Annual CFI
-$188.60 K
-$19.00 K-11.20%
August 31, 2024
Summary
- As of February 8, 2025, LEXX annual cash flow from investing activities is -$188.60 thousand, with the most recent change of -$19.00 thousand (-11.20%) on August 31, 2024.
- During the last 3 years, LEXX annual CFI has fallen by -$382.50 thousand (-197.27%).
- LEXX annual CFI is now -127.54% below its all-time high of $684.80 thousand, reached on August 31, 2015.
Performance
LEXX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$37.80 K
+$31.80 K+45.69%
November 30, 2024
Summary
- As of February 8, 2025, LEXX quarterly cash flow from investing activities is -$37.80 thousand, with the most recent change of +$31.80 thousand (+45.69%) on November 30, 2024.
- Over the past year, LEXX quarterly CFI has stayed the same.
- LEXX quarterly CFI is now -105.24% below its all-time high of $721.80 thousand, reached on February 1, 2015.
Performance
LEXX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$186.40 K
+$2200.00+1.17%
November 30, 2024
Summary
- As of February 8, 2025, LEXX TTM cash flow from investing activities is -$186.40 thousand, with the most recent change of +$2200.00 (+1.17%) on November 30, 2024.
- Over the past year, LEXX TTM CFI has stayed the same.
- LEXX TTM CFI is now -127.22% below its all-time high of $684.80 thousand, reached on August 31, 2015.
Performance
LEXX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
LEXX Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -11.2% | 0.0% | 0.0% |
3 y3 years | -197.3% | -8.6% | -18.6% |
5 y5 years | +75.5% | -8.6% | -18.6% |
LEXX Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -197.3% | at low | -71.8% | +45.7% | -231.7% | +6.3% |
5 y | 5-year | -197.3% | +75.5% | -114.0% | +46.5% | -176.6% | +85.4% |
alltime | all time | -127.5% | +91.0% | -105.2% | +97.0% | -127.2% | +91.1% |
Lexaria Bioscience Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Nov 2024 | - | -$37.80 K(-45.7%) | -$186.40 K(-1.2%) |
Aug 2024 | -$188.60 K(+11.2%) | -$69.60 K(+216.4%) | -$188.60 K(+0.6%) |
May 2024 | - | -$22.00 K(-61.4%) | -$187.40 K(-5.8%) |
Feb 2024 | - | -$57.00 K(+42.5%) | -$199.00 K(+13.9%) |
Nov 2023 | - | -$40.00 K(-41.5%) | -$174.70 K(+3.1%) |
Aug 2023 | -$169.60 K(-6.1%) | -$68.40 K(+103.6%) | -$169.50 K(+12.2%) |
May 2023 | - | -$33.60 K(+2.8%) | -$151.10 K(-2.8%) |
Feb 2023 | - | -$32.70 K(-6.0%) | -$155.50 K(-1.1%) |
Nov 2022 | - | -$34.80 K(-30.4%) | -$157.20 K(-13.0%) |
Aug 2022 | -$180.60 K(-193.1%) | -$50.00 K(+31.6%) | -$180.60 K(+38.3%) |
May 2022 | - | -$38.00 K(+10.5%) | -$130.60 K(-20.0%) |
Feb 2022 | - | -$34.40 K(-40.9%) | -$163.30 K(-215.4%) |
Nov 2021 | - | -$58.20 K(<-9900.0%) | $141.50 K(-27.0%) |
Aug 2021 | $193.90 K(-823.5%) | $0.00(-100.0%) | $193.90 K(+7.5%) |
May 2021 | - | -$70.70 K(-126.1%) | $180.30 K(-26.0%) |
Feb 2021 | - | $270.40 K(-4762.1%) | $243.50 K(-1005.2%) |
Nov 2020 | - | -$5800.00(-57.4%) | -$26.90 K(+0.4%) |
Aug 2020 | -$26.80 K(-96.5%) | -$13.60 K(+81.3%) | -$26.80 K(-42.1%) |
May 2020 | - | -$7500.00(<-9900.0%) | -$46.30 K(-96.4%) |
Feb 2020 | - | $0.00(-100.0%) | -$1.28 M(+110.3%) |
Nov 2019 | - | -$5700.00(-82.8%) | -$607.70 K(-21.0%) |
Aug 2019 | -$769.20 K(+395.0%) | -$33.10 K(-97.3%) | -$769.20 K(+0.8%) |
May 2019 | - | -$1.24 M(-284.9%) | -$762.90 K(-269.6%) |
Feb 2019 | - | $670.30 K(-500.9%) | $449.70 K(-289.8%) |
Nov 2018 | - | -$167.20 K(+523.9%) | -$236.90 K(+52.4%) |
Aug 2018 | -$155.40 K(+1502.1%) | -$26.80 K(+0.8%) | -$155.40 K(+20.8%) |
May 2018 | - | -$26.60 K(+63.2%) | -$128.60 K(+26.1%) |
Feb 2018 | - | -$16.30 K(-81.0%) | -$102.00 K(+24.8%) |
Nov 2017 | - | -$85.70 K(<-9900.0%) | -$81.70 K(+742.3%) |
Aug 2017 | -$9700.00(-51.7%) | $0.00(0.0%) | -$9700.00(-32.6%) |
May 2017 | - | $0.00(-100.0%) | -$14.40 K(-2.0%) |
Feb 2017 | - | $4000.00(-129.2%) | -$14.70 K(-52.1%) |
Nov 2016 | - | -$13.70 K(+191.5%) | -$30.70 K(+52.7%) |
Aug 2016 | -$20.10 K(-102.9%) | -$4700.00(+1466.7%) | -$20.10 K(+76.3%) |
May 2016 | - | -$300.00(-97.5%) | -$11.40 K(-78.1%) |
Feb 2016 | - | -$12.00 K(+287.1%) | -$52.10 K(-107.6%) |
Nov 2015 | - | -$3100.00(-177.5%) | $681.70 K(-0.5%) |
Aug 2015 | $684.80 K | $4000.00(-109.8%) | $684.80 K(+8.8%) |
May 2015 | - | -$41.00 K(-105.7%) | $629.20 K(-1.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Feb 2015 | - | $721.80 K(>+9900.0%) | $638.80 K(-869.6%) |
Nov 2014 | - | $0.00(-100.0%) | -$83.00 K(-27.3%) |
Aug 2014 | -$76.30 K(+8.1%) | - | - |
Jul 2014 | - | -$51.60 K(+64.3%) | -$114.20 K(+82.1%) |
Apr 2014 | - | -$31.40 K(+25.6%) | -$62.70 K(+7.4%) |
Jan 2014 | - | -$25.00 K(+303.2%) | -$58.40 K(-17.2%) |
Oct 2013 | -$70.60 K(-74.2%) | -$6200.00(+6100.0%) | -$70.50 K(-22.8%) |
Jul 2013 | - | -$100.00(-99.6%) | -$91.30 K(-68.9%) |
Apr 2013 | - | -$27.10 K(-27.0%) | -$293.10 K(+10.2%) |
Jan 2013 | - | -$37.10 K(+37.4%) | -$266.00 K(-3.0%) |
Oct 2012 | -$274.10 K(-72.7%) | -$27.00 K(-86.6%) | -$274.10 K(-71.7%) |
Jul 2012 | - | -$201.90 K(<-9900.0%) | -$968.60 K(+26.3%) |
Apr 2012 | - | $0.00(-100.0%) | -$766.70 K(-4.9%) |
Jan 2012 | - | -$45.20 K(-93.7%) | -$806.00 K(-19.6%) |
Oct 2011 | -$1.00 M(+251.5%) | -$721.50 K(<-9900.0%) | -$1.00 M(+77.0%) |
Jul 2011 | - | $0.00(-100.0%) | -$566.40 K(0.0%) |
Apr 2011 | - | -$39.30 K(-83.8%) | -$566.40 K(+7.5%) |
Jan 2011 | - | -$241.90 K(-15.2%) | -$527.10 K(+84.8%) |
Oct 2010 | -$285.20 K(+27.4%) | -$285.20 K(<-9900.0%) | -$285.20 K(+158.6%) |
Jul 2010 | - | $0.00(0.0%) | -$110.30 K(-8.5%) |
Apr 2010 | - | $0.00(0.0%) | -$120.60 K(-35.7%) |
Jan 2010 | - | $0.00(-100.0%) | -$187.70 K(-16.1%) |
Oct 2009 | -$223.80 K(-40.5%) | -$110.30 K(+970.9%) | -$223.80 K(-520.7%) |
Jul 2009 | - | -$10.30 K(-84.6%) | $53.20 K(-154.4%) |
Apr 2009 | - | -$67.10 K(+85.9%) | -$97.80 K(-204.4%) |
Jan 2009 | - | -$36.10 K(-121.7%) | $93.70 K(-124.9%) |
Oct 2008 | -$376.40 K(-82.0%) | $166.70 K(-203.3%) | -$376.40 K(-72.3%) |
Jul 2008 | - | -$161.30 K(-229.7%) | -$1.36 M(+12.7%) |
Apr 2008 | - | $124.40 K(-124.6%) | -$1.21 M(-31.5%) |
Jan 2008 | - | -$506.20 K(-38.0%) | -$1.76 M(-15.7%) |
Oct 2007 | -$2.09 M(+36.5%) | -$816.10 K(>+9900.0%) | -$2.09 M(+9.1%) |
Jul 2007 | - | -$7700.00(-98.2%) | -$1.91 M(-2.5%) |
Apr 2007 | - | -$430.40 K(-48.4%) | -$1.96 M(+22.2%) |
Jan 2007 | - | -$834.50 K(+30.1%) | -$1.61 M(+5.1%) |
Oct 2006 | -$1.53 M(+490.2%) | -$641.20 K(+1017.1%) | -$1.53 M(+72.2%) |
Jul 2006 | - | -$57.40 K(-22.6%) | -$888.70 K(+6.9%) |
Apr 2006 | - | -$74.20 K(-90.2%) | -$831.30 K(+9.8%) |
Jan 2006 | - | -$757.10 K | -$757.10 K |
Oct 2005 | -$259.20 K | - | - |
FAQ
- What is Lexaria Bioscience annual cash flow from investing activities?
- What is the all time high annual CFI for Lexaria Bioscience?
- What is Lexaria Bioscience annual CFI year-on-year change?
- What is Lexaria Bioscience quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly CFI year-on-year change?
- What is Lexaria Bioscience TTM cash flow from investing activities?
- What is the all time high TTM CFI for Lexaria Bioscience?
- What is Lexaria Bioscience TTM CFI year-on-year change?
What is Lexaria Bioscience annual cash flow from investing activities?
The current annual CFI of LEXX is -$188.60 K
What is the all time high annual CFI for Lexaria Bioscience?
Lexaria Bioscience all-time high annual cash flow from investing activities is $684.80 K
What is Lexaria Bioscience annual CFI year-on-year change?
Over the past year, LEXX annual cash flow from investing activities has changed by -$19.00 K (-11.20%)
What is Lexaria Bioscience quarterly cash flow from investing activities?
The current quarterly CFI of LEXX is -$37.80 K
What is the all time high quarterly CFI for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly cash flow from investing activities is $721.80 K
What is Lexaria Bioscience quarterly CFI year-on-year change?
Over the past year, LEXX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Lexaria Bioscience TTM cash flow from investing activities?
The current TTM CFI of LEXX is -$186.40 K
What is the all time high TTM CFI for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM cash flow from investing activities is $684.80 K
What is Lexaria Bioscience TTM CFI year-on-year change?
Over the past year, LEXX TTM cash flow from investing activities has changed by $0.00 (0.00%)